Sedana Medical AB (publ)

DB:7D2A Stock Report

Market Cap: €202.6m

Sedana Medical Past Earnings Performance

Past criteria checks 0/6

Sedana Medical's earnings have been declining at an average annual rate of -27.9%, while the Medical Equipment industry saw earnings growing at 0.5% annually. Revenues have been growing at an average rate of 13.8% per year.

Key information

-27.9%

Earnings growth rate

-24.9%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate13.8%
Return on equity-2.3%
Net Margin-13.8%
Next Earnings Update23 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Sedana Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:7D2A Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 24165-2315421
31 Dec 23154-6015521
30 Sep 23145-5716020
30 Jun 23137-5816920
31 Mar 23127-7117020
31 Dec 22123-7417020
30 Sep 22133-5417121
30 Jun 22135-6215621
31 Mar 22148-6815321
31 Dec 21159-5814820
30 Sep 21159-5313616
30 Jun 21152-5112813
31 Mar 21153-3811411
31 Dec 20142-271028
30 Sep 20116-227813
30 Jun 20111-147211
31 Mar 2088-12638
31 Dec 1972-16567
30 Sep 1967-13610
30 Jun 1963-11550
31 Mar 1960-10510
31 Dec 1858-7470
30 Sep 1853-3430
30 Jun 1851-4410
31 Mar 1847-3370
31 Dec 1742-4320
30 Sep 1741-3300
30 Jun 17390280
31 Mar 17360240
31 Dec 16341220
31 Dec 1528-1180

Quality Earnings: 7D2A is currently unprofitable.

Growing Profit Margin: 7D2A is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 7D2A is unprofitable, and losses have increased over the past 5 years at a rate of 27.9% per year.

Accelerating Growth: Unable to compare 7D2A's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7D2A is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-6.1%).


Return on Equity

High ROE: 7D2A has a negative Return on Equity (-2.31%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.